T 2255/12 of 31.05.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T225512.20160531
- Date of decision
- 31 May 2016
- Case number
- T 2255/12
- Petition for review of
- -
- Application number
- 06778240.9
- IPC class
- A61K 9/36A61K 38/46
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Controlled release pharmaceutical compositions for acid labile drugs
- Applicant name
- Abbott Laboratories GmbH
- Opponent name
- Aptalis Pharma S.r.l.
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56
- Keywords
- Amendments - allowable (yes)
Inventive step - (yes) - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form on the basis of the following documents:
claims: 1 to 14 filed as main request with letter of 2 January 2013
description of the patent specification with replacement pages 2, 3, 4, 6, 7, 8 and 11 filed for the main request with letter of 4 April 2016.